These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7475322)

  • 1. Inhibition of human immunodeficiency virus type 1 (HIV) gag gene expression by an antisense oligodeoxynucleotide phosphorothioate.
    Anazodo MI; Wainberg MA; Friesen AD; Wright JA
    Leukemia; 1995 Oct; 9 Suppl 1():S86-8. PubMed ID: 7475322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
    Anazodo MI; Wainberg MA; Friesen AD; Wright JA
    J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.
    Kinchington D; Galpin S; Jaroszewski JW; Ghosh K; Subasinghe C; Cohen JS
    Antiviral Res; 1992 Jan; 17(1):53-62. PubMed ID: 1736810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome.
    Anazodo MI; Salomon H; Friesen AD; Wainberg MA; Wright JA
    Gene; 1995 Dec; 166(2):227-32. PubMed ID: 8543166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner.
    Rizvi TA; Schmidt RD; Lew KA
    Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
    Lisziewicz J; Sun D; Weichold FF; Thierry AR; Lusso P; Tang J; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7942-6. PubMed ID: 8058738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative levels of inhibition of p24 gene expression by different 20-mer antisense oligonucleotide sequences targeting nucleotides + 1129 to + 1268 of the HIV-1 gag genome: an analysis of mechanism.
    Anazodo MI; Duta E; Friesen AD; Wright JA
    Biochem Biophys Res Commun; 1996 Dec; 229(1):305-9. PubMed ID: 8954123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
    Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Huang Y; Zhang L; Ho DD
    Virology; 1998 Jan; 240(1):36-49. PubMed ID: 9448687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gene expression of human foamy virus does not require a post-transcriptional transactivator.
    Lee AH; Lee HY; Sung YC
    Virology; 1994 Oct; 204(1):409-13. PubMed ID: 7522374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides.
    Moriya K; Matsukura M; Kurokawa K; Koike K
    Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High variability of the gag/pol transframe region among HIV-1 isolates.
    Candotti D; Chappey C; Rosenheim M; M'Pelé P; Huraux JM; Agut H
    C R Acad Sci III; 1994 Feb; 317(2):183-9. PubMed ID: 7994608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
    Agrawal S; Tang JY
    Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.